Who Exports Ertapenem from India — 54 Suppliers Behind a $109.0M Market
India's ertapenem export market is supplied by 54 active exporters who collectively shipped $109.0M across 780 shipments. EUGIA PHARMA SPECIALITIES LIMITED leads with a 70.4% market share, followed by JODAS EXPOIM PRIVATE LIMITED and GLAND PHARMA LIMITED. The top 5 suppliers together control 91.4% of total export value, reflecting a concentrated market structure.
Top Ertapenem Exporters from India — Ranked by Export Value
EUGIA PHARMA SPECIALITIES LIMITED is the leading ertapenem exporter from India, holding a 70.4% share of the $109.0M market across 780 shipments from 54 exporters. The top 5 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, JODAS EXPOIM PRIVATE LIMITED, GLAND PHARMA LIMITED, DR.REDDY'S LABORATORIES LTD, GLAND PHARMA LTD — collectively control 91.4% of total export value, indicating a highly concentrated market. Individual shares are: EUGIA PHARMA SPECIALITIES LIMITED (70.4%), JODAS EXPOIM PRIVATE LIMITED (6.8%), GLAND PHARMA LIMITED (6.4%), DR.REDDY'S LABORATORIES LTD (5.6%), GLAND PHARMA LTD (2.2%).
Top Ertapenem Exporters from India
Ranked by export value · 54 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED ERTAPENEM FOR INJECTION 1 G/VIALERTAPENERTAPENEM FOR INJECTION 1 G/VIAL(ERTAPENERTAPENEM FOR INJECTION 1 G/VIAL (ERTAPE | $76.7M | 11 | 70.4% |
| 2 | JODAS EXPOIM PRIVATE LIMITED ERTAPENEM FOR INJECTION 1GRAM/VIAL #1 -HARMLESS MEDICINE- ERTAPENEM FOR INJECTIERTAPENEM FOR INJECTION 1 GRAM/VIAL #1AS PER DOCUMENT | $7.4M | 1 | 6.8% |
| 3 | GLAND PHARMA LIMITED ERTAPENEM FOR INJECTION 1 G/VIALERTAPENERTAPENEM FOR INJECTION 1 G/VIAL(ERTAPENERTAPENEM FOR INJECTION 1G/VIAL 20ML VIAL | $7.0M | 4 | 6.4% |
| 4 | DR.REDDY'S LABORATORIES LTD ERTAPENEM FOR INJECTION 1 G/VIALERTAPENERTAPENEM FOR INJECTION 1 G/VIAL(ERTAPENERTAPENEM FOR INJECTION 1G/VIAL 20ML VIAL | $6.1M | 2 | 5.6% |
| 5 | GLAND PHARMA LTD ERTAPENEM FOR INJECTION 1 G/VIALERTAPENERTAPENEM FOR INJECTION 1 G/VIAL(ERTAPENERTAPENEM FOR INJECTION 1G/VIAL 20ML VIAL | $2.4M | 3 | 2.2% |
| 6 | DR REDDYS LABORATORIES LIMITED ERTAPENEM FOR INJECTION 1 G/VIALERTAPENERTAPENEM FOR INJECTION 1 G/VIAL(ERTAPENERTAPENEM FOR INJECTION 1G/VIAL 20ML VIAL | $2.3M | 2 | 2.1% |
| 7 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $1.9M | 2 | 1.7% |
| 8 | UNITED BIOTECH PRIVATE LIMITED ERTAPENEM FOR INJECTION IG/ERTAPENEM FOR INJECTION 1G/PHARMA PRODUCT-LYORPEM ERTAPENEM SODIUM | $1.3M | 9 | 1.2% |
| 9 | DR REDDY S LABORATORIES LIMITED ERTAPENEM FOR INJECTION 1 G/VIALERTAPENERTAPENEM FOR INJECTION 1 G/VIAL(ERTAPENERTAPENEM FOR INJECTION 1G/VIAL 20ML VIAL | $796.3K | 2 | 0.7% |
| 10 | SRS PHARMACEUTICALS PRIVATE LIMITED | $548.9K | 1 | 0.5% |
| 11 | LOTUS INTERNATIONAL | $273.1K | 1 | 0.3% |
| 12 | MEDIOR HEALTHCARE PRIVATE LIMITED PHARMA PRODUCT-LYORPEM ERTAPENEM SODIUMERTAPENEM FOR INJECTION VIAL 1G | $260.1K | 1 | 0.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Ertapenem exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Eugia Pharma Specialities Limited | Approved | Yes | No | 179 | Received FDA approval for Pazopanib Tablets in December 2024; WHO-GMP certified |
| Gland Pharma Limited | Approved | Unknown | Yes | Unknown | Received Establishment Inspection Report from FDA in August 2022; EU GMP certifi |
| Dr. Reddy's Laboratories Ltd | Approved | Yes | Yes | Unknown | Holds multiple FDA approvals; WHO-GMP and EU GMP certified. |
| Sun Pharmaceutical Industries Limited | Approved | Yes | Yes | Unknown | Holds multiple FDA approvals; WHO-GMP and EU GMP certified. |
| United Biotech Private Limited | Not Listed | Yes | No | Unknown | WHO-GMP certified facility. |
| SRS Pharmaceuticals Private Limited | Not Listed | Yes | No | Unknown | WHO-GMP certified facility. |
| Lotus International | Not Listed | Yes | No | Unknown | WHO-GMP certified facility. |
| Medior Healthcare Private Limited | Not Listed | Yes | No | Unknown | WHO-GMP certified facility. |
TransData Nexus reviewed the regulatory standing of 8 leading Ertapenem exporters from India. 4 hold US FDA facility approvals, 7 maintain WHO-GMP certification, and 3 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Ertapenem sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as "Genome Valley," is a leading hub for pharmaceutical manufacturing and biotech research in India. The city hosts major companies like Dr. Reddy’s Laboratories and Aurobindo Pharma, contributing significantly to the production of Active Pharmaceutical Ingredients (APIs) and bulk drugs. This concentration of expertise and infrastructure makes Hyderabad a pivotal center for the production of antibiotics like Ertapenem.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations and finished dosage forms. Companies such as Zydus Lifesciences and Intas Pharmaceuticals are headquartered here, focusing on the development and manufacturing of generic drugs and complex formulations. This region's emphasis on formulations complements the bulk drug production in other clusters, ensuring a seamless supply chain for antibiotics like Ertapenem.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a critical export gateway for pharmaceutical products. With a high concentration of pharmaceutical units, this region facilitates the export of antibiotics, including Ertapenem, to international markets. The well-established infrastructure and proximity to major ports enhance the efficiency of the supply chain, supporting India's position as a global pharmaceutical exporter.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives and supportive government policies. This region hosts numerous pharmaceutical companies producing a wide range of drugs, including antibiotics. The cost advantages and regulatory support make Baddi-Nalagarh an attractive location for manufacturing Ertapenem and other pharmaceuticals.
5Sourcing Recommendations
- Diversify Supplier Base: Given that the top five exporters account for 91.4% of Ertapenem exports, it's advisable to diversify the supplier base to mitigate risks associated with over-reliance on a few sources.
- Leverage Cluster Specializations: Engage with suppliers in Hyderabad for bulk drug requirements and those in Ahmedabad-Vadodara for formulations to optimize the supply chain.
- Utilize Export Infrastructure: Collaborate with companies in the Mumbai-Thane-Raigad region to take advantage of established export channels and logistics.
- Explore Cost-Effective Manufacturing: Consider sourcing from manufacturers in Baddi-Nalagarh to benefit from tax incentives and cost-effective production capabilities.
By strategically engaging with these pharmaceutical clusters, companies can enhance their supply chain resilience and efficiency in sourcing Ertapenem.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Ertapenem exporters from India
Eugia Pharma Specialities Limited — Eugia partners with MPP to develop Nilotinib for LMICs
Eugia Pharma Specialities Limited entered into a voluntary sub-licensing agreement with the Medicines Patent Pool (MPP) to develop and market Nilotinib capsules, an anti-cancer drug, in 44 low and middle-income countries. - IMPACT: This collaboration may enhance Eugia's global presence, potentially influencing its Ertapenem export strategies.
Impact: This collaboration may enhance Eugia's global presence, potentially influencing its Ertapenem export strategies.
Aurobindo Pharma Limited — Aurobindo evaluates options for Eugia Pharma restructuring
Aurobindo Pharma announced that its Committee of Independent Directors would comprehensively evaluate all options regarding the restructuring of its wholly-owned subsidiary, Eugia Pharma Specialities Limited. - IMPACT: Potential restructuring could affect Eugia's operational focus, possibly impacting Ertapenem production and exports.
Impact: Potential restructuring could affect Eugia's operational focus, possibly impacting Ertapenem production and exports.
Eugia Pharma Specialities Limited — USFDA completes audit of Eugia's Unit III with 11 observations
The US Food and Drug Administration (USFDA) inspected Eugia Pharma's Unit-III, a formulation manufacturing facility, from January 27 to February 6, 2026, resulting in 11 procedural observations. - IMPACT: Addressing these observations is crucial to maintain regulatory compliance, ensuring uninterrupted Ertapenem exports.
Impact: Addressing these observations is crucial to maintain regulatory compliance, ensuring uninterrupted Ertapenem exports.
Common Questions — Ertapenem Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which ertapenem supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, EUGIA PHARMA SPECIALITIES LIMITED leads with 537 recorded shipments worth $76.7M. JODAS EXPOIM PRIVATE LIMITED (17 shipments) and GLAND PHARMA LIMITED (29 shipments) are also established high-volume exporters.
Q How many ertapenem manufacturers are there in India?
India has 54 active ertapenem exporters with a combined export market of $109.0M across 780 shipments to 46 countries. The top 5 suppliers hold 91.4% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for ertapenem from India?
Average FOB unit price: $20.70 per unit, ranging from $0.05 to $2205.87. Average shipment value: $139.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 54 verified Indian exporters of Ertapenem ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 780 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 46 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
780 Verified Shipments
54 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists